Account
Lowe Lintas Delhi bags Pernod Ricard India account
MUMBAI: Pernod Ricard India, the multinational alcohol and beverage company in India, has appointed Lowe Lintas Delhi as its brand communication partner, after being shortlisted from a multi-agency pitch.
This makes them the second agency that works the wide portfolio of brands in a dual agency format.
The agency will be handling the mandate of some of the brands marketed by Pernod Ricard India including Absolut, Blenders Pride and Nine Hills among others.
Lowe Lintas Delhi president Naveen Gaur said, “It’s a very exciting and challenging category but the more thrilling part is working with Pernod Ricard India. They have a bouquet of some iconic brands like Absolut and Blenders Pride and our task will be to take the brands further in a very unique and a disruptive way. We are really looking forward to our association with Pernod Ricard India to create some outstanding and out-of-the-box work.”
Pernod Ricard India executive director of business development Sumeet Lamba added, “We are delighted to be associated with Lowe Lintas Delhi who will partner us in our journey ahead for some of our core brands. The team showcased their ability to think in a very non-linear way and that’s what made the selection decision easy for us, we look forward to harnessing Lowe Lintas’ expertise to make sure the team delivers some amazing work.”
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”
